|
CV Information
 PROFESOR MADYA DR. SANIHAH BINTI ABDUL HALIM
| |
|---|---|
|
Grant's Name,"Project's Title" (Research Period)(Role)[Sponsorship]
| |
| 1 | EXTERNAL GRANT COMMUNITY (BJIM), "PROJEK STROKE REPERFUSION THERAPY KELANTAN ROADSHOW 2022: THROMBOLYSIS AND THROMBECTOMY (T&T) TRAINING WORLSHOP" (01.04.2022 - 30.04.2023) (Principal) [ PENUMBRA COMPANY INC. ] - Source: eR&I |
| 2 | , "A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED, EVENT-DRIVEN STUDY TO DEMONSTRATE THE EFFICACY AND SAFETY OF MILVEXIAN, AN ORAL FACTOR XIA INHIBITOR, FOR STROKE PREVENTION AFTER AN ACUTE ISCHEMIC STROKE OR HIGHRISK TRANSIENT ISCHEMIC ATTACK." (10.12.2023 - 15.12.2024) [ JANSSEN ] - Source: HCMSv3 |
| 3 | , "OPTIMAL POST RTPA-IV MONITORING IN ISCHEMIC STROKE" (09.11.2022 - 09.11.2023) [ The George Institue ] - Source: HCMSv3 |
| 4 | , "TRIPLE THERAPY PREVENTION OF RECURRENT INTRACEREBRAL DISEASE EVENT TRIAL (TRIDENT)" (30.05.2019 - 30.05.2024) [ George Clinical Institute ] - Source: HCMSv3 |
| 5 | , "TRIPLE THERAPY PREVENTION OF RECURRENT INTRACEREBRAL DISEASE EVENT TRIAL (TRIDENT)" (28.01.2019 - 31.05.2021) [ The George Institute/University of Sidney Australia ] - Source: HCMSv3 |
| 6 | , "TRIDENT (TRIPLE THERAPY PREVENTION OF RECURRENT INTRACEREBRAL DISEASE EVENNTS TRIAL)" (01.11.2018 - 31.10.2021) [ NHMRC AUSTRALIA ] - Source: HCMSv3 |